Park Ha Biological Technology Co., Ltd.(PHH)
Search documents
Park Ha Biological Technology Co., Ltd.(PHH) - Prospectus(update)
2025-12-05 19:17
As filed with the U.S. Securities and Exchange Commission on December 5, 2025. Registration No. 333-290410 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ AMENDMENT NO. 2 To FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ___________________________________ Park Ha Biological Technology Co., Ltd. +86 400 012 7562 (Address, including zip code, and telephone number, including area code, of principal executive offices) _______________ ...
Onity Group Schedules Conference Call - Third Quarter 2025 Results and Business Update
The Manila Times· 2025-10-28 10:56
Core Points - Onity Group Inc. will hold a conference call on November 6, 2025, at 8:30 a.m. (ET) to discuss its third quarter 2025 operating results and provide a business update [1] - The conference call can be accessed by dialing (833) 316-1983 or (785) 838-9310, with a conference ID "Onity" [2] - An investor presentation will be available on the Shareholder Relations page prior to the call, and a replay will be accessible approximately two hours after the call [3] Company Overview - Onity Group Inc. is a leading non-bank financial services company that provides mortgage servicing and originations solutions through its primary brands, PHH Mortgage and Liberty Reverse Mortgage [4] - PHH Mortgage is one of the largest servicers in the U.S., offering various servicing and lending programs [4] - Liberty Reverse Mortgage is among the largest reverse mortgage lenders in the nation, focusing on loans that assist customers with personal and financial needs [4]
Agency Approval, Audit, Agent Targeting, Social Media Compliance Tools; Aggregator and Non-Agency News
Mortgage News Daily· 2025-10-23 15:46
Economic Impact and Industry Trends - The slowing economy is affecting residential lending, with potential government shutdowns negatively impacting U.S. GDP [1] - Agency loans are being sold to aggregators, indicating a loss of market share for Freddie Mac and Fannie Mae [7] - PennyMac reported a 15% year-over-year increase in volume to $36.5 billion, with profitability nearly doubling from the prior quarter [7] Product Innovations and Offerings - Flyhomes introduced a Buy Before You Sell program that allows clients to access home equity before selling, saving them $12,500 on average [2] - PHH Mortgage launched the FlexIQ Non-Agency program suite, replacing previous non-QM offerings [9][10] - JMAC Lending's Limited Docs Non-QM program simplifies borrower qualification with a streamlined process [11] Technology and Compliance - An integrated approach to mortgage technology is transforming lender and servicer operations, enhancing customer experiences [4] - ActiveComply highlighted potential compliance pitfalls in social media strategies for mortgage institutions [3] Market Dynamics and Regulatory Environment - The Federal Reserve proposed easing capital requirements for major Wall Street banks, which could result in a 3% to 7% increase in total capital [16] - The potential for GSEs to purchase up to $300 billion of their own securities is being discussed to lower mortgage rates [13][14]
Park Ha Biological Technology Co., Ltd.(PHH) - Prospectus(update)
2025-09-25 00:05
As filed with the U.S. Securities and Exchange Commission on September 24, 2025. Registration No. 333-290410 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ AMENDMENT NO. 1 Phase 2, Wuxi International Life Science Innovation Campus 196 Jinghui East Road Xinwu District, Wuxi, Jiangsu Province People's Republic of China 214000 +86 400 012 7562 (Address, including zip code, and telephone number, including area code, of principal executive offices) ___ ...
Park Ha Biological Technology Co., Ltd.(PHH) - Prospectus
2025-09-19 20:56
As filed with the U.S. Securities and Exchange Commission on September 19, 2025. Registration No. 333-[*] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ___________________________________ Park Ha Biological Technology Co., Ltd. (Exact name of registrant as specified in its charter) ___________________________________ Not Applicable (Translation of Registrant's Name into English) ___________________________________ | C ...
多只中概仙股陷“拉高出货”疑云:社媒热炒后暴跌80%,投资者损失数十亿美元
智通财经网· 2025-08-18 11:18
Group 1 - A significant drop in stock prices of several Chinese micro-cap stocks listed in the US has resulted in investors losing billions of dollars, raising concerns about a potential "pump and dump" scheme [1] - Seven specific stocks, including Concorde International (CIGL.US) and Austin Technology (OST.US), have seen declines exceeding 80% in recent trading days, leading to a total market value loss of $3.7 billion [1] - Prior to the sharp declines, these stocks had experienced substantial increases and were promoted on social media platforms like WhatsApp [1] Group 2 - Brain Regen Technologies (RGC.US) has seen its stock price increase nearly 10,000% this year, with no current evidence linking the company to stock price fluctuations [2] - The FBI reported a 300% increase in complaints related to "pump and dump" stock fraud over the past year, indicating a rise in investor victimization [2] - Fraud groups are reportedly using social media ads and "investment club" promotions to lure investors, sometimes impersonating legitimate brokerage firms or well-known stock analysts [2]
朴荷上涨24.45%,报0.82美元/股,总市值2162.44万美元
Jin Rong Jie· 2025-08-05 13:52
Core Insights - Park Ha (PHH) opened with a significant increase of 24.45%, reaching a stock price of $0.82 per share, with a trading volume of $1.3684 million and a total market capitalization of $21.6244 million [1] Financial Performance - As of October 31, 2024, Park Ha reported total revenue of 2.3819 million RMB, reflecting a year-on-year decrease of 3.14% [1] - The net profit attributable to the parent company was 478,600 RMB, showing a substantial year-on-year decline of 43.83% [1] Company Overview - Park Ha Biotechnology Co., Ltd. is a Cayman Islands-registered holding company primarily operated by its domestic entity, Jiangsu Park Ha Biotechnology Co., Ltd. [1] - The company's business focuses on developing its own skincare brand, direct selling skincare products, and promoting franchise alliances [1] - The "Park Ha" brand specializes in providing solutions for problematic skin, established in 2016, with its first store opening in 2017 [1] Franchise Operations - As of April 30, 2024, and October 31, 2023, the company had 43 and 38 franchisees in China, respectively, compared to 49 franchisees in 2022 [1] - Among these, 41, 36, and 45 franchisees operated under the "Park Ha" brand name in the respective years [1]
美股异动丨中概股华米科技大涨34%




Ge Long Hui A P P· 2025-08-05 00:33
Group 1 - The top five gaining Chinese concept stocks at the close were Lichen International, ATA Creativity Global, Huami Technology, Puhua Biotechnology, and Feitian Zhaoye, with respective gains of 48.81%, 36.11%, 34%, 24.45%, and 23.46% [1] - Lichen International's latest price was 5.610, with a gain of 1.840 and a trading volume of 14.39 million [1] - ATA Creativity Global's latest price was 1.470, with a gain of 0.390 and a trading volume of 7.29 million [1] Group 2 - Huami Technology's latest price was 17.420, with a gain of 4.420 and a trading volume of 22.89 million [1] - Puhua Biotechnology's latest price was 0.8199, with a gain of 0.1611 and a trading volume of 1.36 million [1] - Feitian Zhaoye's latest price was 1.0000, with a gain of 0.1900 and a trading volume of 16.93 million [1]
朴荷上涨17.76%,报0.776美元/股,总市值2046.13万美元
Jin Rong Jie· 2025-08-04 16:53
Core Viewpoint - Park Ha (PHH) experienced a significant stock price increase of 17.76%, reaching $0.776 per share, with a total market capitalization of $20.46 million as of August 5 [1] Financial Performance - As of October 31, 2024, Park Ha reported total revenue of 2.38 million RMB, reflecting a year-on-year decrease of 3.14% [1] - The net profit attributable to the parent company was 478,600 RMB, showing a substantial year-on-year decline of 43.83% [1] Company Overview - Park Ha Biotechnology Co., Ltd. is a Cayman Islands-registered holding company primarily operated by its domestic subsidiary, Jiangsu Park Ha Biotechnology Co., Ltd. [1] - The company's business focuses on developing its own skincare brand, direct selling skincare products, and promoting franchise alliances [1] - The "Park Ha" brand, established in 2016, aims to provide solutions for problematic skin and opened its first store in 2017 [1] Franchise Operations - As of April 30, 2024, and October 31, 2023, the company had 43 and 38 franchisees in China, respectively, with 41 and 36 operating under the "Park Ha" name [1] - In 2022, the company had a total of 49 franchisees [1]
朴荷上涨2.94%,报0.788美元/股,总市值2076.98万美元
Jin Rong Jie· 2025-07-30 14:26
Core Insights - Park Ha (PHH) experienced a stock price increase of 2.94%, reaching $0.788 per share, with a total market capitalization of $20.77 million as of July 30 [1] - Financial data indicates that as of October 31, 2024, Park Ha's total revenue was 2.38 million RMB, reflecting a year-on-year decrease of 3.14%, while net profit attributable to the parent company was 478,600 RMB, down 43.83% year-on-year [1] Company Overview - Park Ha Biotechnology Co., Ltd. is a Cayman Islands-registered holding company primarily operated by its domestic entity, Jiangsu Park Ha Biotechnology Co., Ltd. [1] - The company's business focuses on developing its own skincare brand, direct sales of skincare products, and promoting franchise alliances [1] - The "Park Ha" brand, established in 2016, aims to provide solutions for problematic skin and opened its first store in 2017 [1] Franchise Operations - As of April 30, 2024, and October 31, 2023, the company had 43 and 38 franchisees in China, respectively, compared to 49 franchisees in 2022 [1] - Among these, 41, 36, and 45 franchisees operated under the "Park Ha" name in the respective years [1]